State that they have been exposed to an infectious ATD case, other than seasonal influenza. (I) Identify any operations or conditions in which respiratory protection will be required. (K) Include a medical services program consistent with subsection (h), including the provision of all vaccinations as recommended by applicable public health guidelines for the specific laboratory operations, and the methods for providing investigation and medical follow up for exposure incidents (laboratory). conditions are acceptable to you, please indicate your agreement by clicking below on the button labeled I Agree. or other proprietary rights notices included in the materials. The circumstances under which the exposure incident occurred; 3. The employer shall ensure that all employee medical records required by this section are: 2. (E) The methods of implementation of subsections (e), (g), (h), (i) and (j) as they apply to that facility, service or work operation.
(H) The procedures the employer will use to provide medical services, including recommended vaccinations and follow-up, as required in subsection (h). The employer shall notify the other employer(s) within a timeframe that will both provide reasonable assurance that there will be adequate time for the employee to receive effective medical intervention to prevent disease or mitigate the disease course, and will also permit the prompt initiation of an investigation to identify exposed employees. An employee who in the scope of their current job may be assigned to tasks which may require the use of a respirator, in accordance with subsection (g). DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK BELOW ON THE BUTTON LABELLED I Disagree AND
The written procedures shall be available at the worksite. 2.
OBLIGATION OF THE ORGANIZATION. EXCEPTION to subsection (d)(1): Employers with laboratory operations in which employees do not have direct patient contact may establish, implement and maintain an effective, written Biosafety Plan meeting the requirements of subsection (f) in lieu of an Exposure Control Plan for those operations. A referring employer is required only to comply with the provisions of subsection (a), subsection (c), including all parts of Section 5199 referred to in subsection (c), and subsection (j).
If you do not agree to the terms and conditions, you may not access or use the software. (E) Identify and describe the use of engineering controls, including containment equipment and procedures, to be used to minimize exposure to infectious or potentially infectious laboratory aerosols. Assessment procedures shall be in accordance with applicable public health guidelines.
Either: (1) an aerosol transmissible disease transmitted through dissemination of airborne droplet nuclei, small particle aerosols, or dust particles containing the disease agent for which AII is recommended by the CDC or CDPH, as listed in Appendix A, or (2) the disease process caused by a novel or unknown pathogen for which there is no evidence to rule out with reasonable certainty the possibility that the pathogen is transmissible through dissemination of airborne droplet nuclei, small particle aerosols, or dust particles containing the novel or unknown pathogen. Health care provider. The vaccine(s) is contraindicated for medical reasons.
(A) The employer shall establish and maintain an accurate medical record for each employee with occupational exposure, in accordance with Section 3204, Access to Employee Exposure and Medical Records, of these orders. Infection with. (K) The procedures the employer will use to communicate with its employees and other employers regarding the suspected or confirmed infectious disease status of persons to whom employees are exposed in the course of their duties, in accordance with subsection (h). 2. The analysis shall also record the basis for any determination that an employee need not be included in post-exposure follow-up because the employee did not have a significant exposure or because a PLHCP determined that the employee is immune to the infection in accordance with applicable public health guidelines. (1) Each employer who has any employee with occupational exposure shall provide the employee with medical services for tuberculosis and other ATDs, and infection with ATPs and ATPs-L, in accordance with applicable public health guidelines, for the type of work setting and disease. consequential damages arising out of the use of such information or material. Long term health care facilities and hospices, 8. (D) The employer shall establish, implement, and maintain effective procedures for providing vaccinations against seasonal influenza to all employees with occupational exposure, in accordance with subsection (h)(10). (5) Medical evaluation: The employer shall provide a medical evaluation, in accordance with Section 5144(e) of these orders, to determine the employee's ability to use a respirator before the employee is fit tested or required to use the respirator. EXCEPTION to subsection (h)(3): Research and production laboratories in which. EXCEPTION: Research and production laboratories do not need to include training on surveillance for LTBI if. Note: All influenza virus vaccine and pneumococcal vaccine CPT procedure codes are covered under home health. This shall include the procedures the employer will use to document the lack of availability of a recommended vaccine. (6) The employer shall establish a system of medical services for employees which meets the following requirements: (A) The employer shall make available to all health care workers with occupational exposure all vaccinations recommended by the CDPH as listed in Appendix E in accordance with subsection (h). are authorized to use CDT only as contained in the following authorized materials and solely for internal use by
(1) The employer shall establish, implement, and maintain an effective, written ATD Exposure Control Plan (Plan) which is specific to the work place or operation(s), and which contains all of the elements in subsection (d)(2). EXCEPTION to subsection (h)(5): Where the employer cannot implement these procedures because of the lack of availability of vaccine, the employer shall document efforts made to obtain the vaccine in a timely manner and inform employees of the status of the vaccine availability, including when the vaccine is likely to become available. The ADA is a third
Use of CDT is limited
(2) The Plan shall contain all of the following elements: (A) The name(s) or title(s) of the person(s) responsible for administering the Plan. The procedures shall include methods to inform individuals entering the facility, being transported by employees, or otherwise in close contact with employees, of the source control practices implemented by the employer. The contents or a summary of the training session(s); 3. v. The person performing the test is knowledgeable about the assessment of air handling systems. Referral. These materials contain Current Dental Terminology (CDT), copyright 2008 American Dental Association (ADA). (1) Scope. Public health guidelines. (C) The employer shall establish, implement, and maintain an effective surveillance program for LTBI in accordance with subsections (h)(3) and (h)(4). employees and agents within your organization within the United States and its territories. The plan shall include work practices, decontamination facilities, and appropriate personal protective equipment and respiratory protection for such events. The initial assessment of persons who are potentially AirID or ATD cases by a health care provider in order to determine whether they need airborne infection isolation or need to be referred for further medical evaluation or treatment to make that determination.
Facilities where high hazard procedures, as defined in subsection (b), are performed, 6. A statement that the employee has been told about any medical conditions resulting from exposure to TB, other RATD, or ATP-L that require further evaluation or treatment and that the employee has been informed of treatment options; and. In this context, elevated means higher than what is considered ordinary for employees having direct contact with the general public outside of the facilities, service categories and operations listed in subsection (a)(1) of this standard. EXCEPTION 1 to subsection (g)(3)(B): Where a high hazard procedure is performed by placing the patient in a booth, hood or other ventilated enclosure that effectively contains and removes the aerosols resulting from the procedure, and the employee remains outside of the enclosure, the employee may use a respirator meeting the requirements of subsection (g)(3)(A). The administrator shall also identify in writing the job categories in which employees have occupational exposure to ATDs.
2. Whether an additional vaccination dose is required, and if so, the date the additional vaccination dose should be provided. A person who works in a health care facility, service or operation, or who has occupational exposure in a public health service described in subsection (a)(1)(D). (3) In regards to any disease or condition not addressed by the above guidelines, recommendations made by the CDPH or the local health officer pursuant to authority granted under the Health and Safety Code and/or Title 17, California Code of Regulations. Employers who provide fit-test screening, in accordance with the exception to subsection (g)(6)(B)3 shall retain the screening record for two years. 1. In addition to source control measures, these procedures shall include, to the extent feasible: (A) placement of the person requiring referral in a separate room or area; (B) provision of separate ventilation or filtration in the room or area; and. Negative pressure shall be maintained in AII rooms or areas.
4. Biosafety in Microbiological and Biomedical Laboratories (BMBL). THE
Airborne precautions shall be in accordance with Guidelines for Preventing the Transmission of. (1) Employers who conduct hazardous waste and emergency response operations, as defined in Section 5192 of these orders, shall also comply with the applicable requirements of Section 5192. In facilities, services, or operations in which there is occupational exposure and which meet the criteria specified by (a)(3)(A), employers are only required to comply with the following provisions: (1) The employer shall designate a person as the administrator who will be responsible for the establishment, implementation and maintenance of effective written infection control procedures to control the risk of transmission of aerosol transmissible diseases.
(L) The procedures the employer will use to communicate with other employers regarding exposure incidents, including procedures for providing or receiving notification to and from health care providers about the disease status of referred or transferred patients, in accordance with subsection (h). If there is no AII room or area available within this time, the employer shall transfer the individual to another suitable facility in accordance with subsection (e)(5)(B)2.
(C) Each employer who becomes aware that his or her employees may have been exposed to an RATD case or suspected case, or to an exposure incident involving an ATP-L shall do all of the following: 1. NOTE to subsection (g)(2): The respiratory protection program may be incorporated into the ATD Exposure Control Plan or the Biosafety Plan. Exposure from work activity or working conditions that is reasonably anticipated to create an elevated risk of contracting any disease caused by ATPs or ATPs-L if protective measures are not in place.
A significant exposure to an aerosol containing an ATP-L, without the benefit of applicable exposure control measures required by this section.
NOTE: Variants of the human influenza virus that typically occur from season to season are not considered novel or unknown ATPs if they do not differ significantly in virulence or transmissibility from existing seasonal variants.
Any employer that operates a facility, service, or operation in which there is occupational exposure and which refers AirID cases and suspected cases to other facilities. 8. (3) The employer shall provide information about infectious disease hazards to any contractor who provides temporary or contract employees who may be reasonably anticipated to have occupational exposure so that the contractors can institute precautions to protect their employees. Such procedures include, but are not limited to, sputum induction, bronchoscopy, aerosolized administration of pentamidine or other medications, and pulmonary function testing. The disease or pathogen to which employees may have been exposed; 4. 4. CDC. YOU ARE ACTING.
End Users do not
(J) An opportunity for interactive questions and answers with a person who is knowledgeable in the subject matter as it relates to the workplace that the training addresses and who is also knowledgeable in the employer's infection control procedures. (3) The employer shall implement feasible engineering and work practice controls, in accordance with the risk assessment performed in subsection (f)(2), to minimize employee exposures to ATPs-L. Where exposure still remains after the institution of engineering and work practice controls, the employer shall provide, and ensure that employees use, personal protective equipment and, where necessary to control exposure, respiratory protection.
CDT and other content contained therein, is with The Department of Medical Assistance Services or the CMS; and no
Not intend to provide further medical services to AirID cases and suspected cases beyond first aid, initial treatment or screening and referral as described in subsections (a)(3)(A)1 and (a)(3)(A)2 immediately above. This determination shall be documented in accordance with the ATD Plan and shall be reviewed by the employer and employees at least annually in accordance with subsection (d)(3). The date of contact and contact information for any other employer who either notified the employer or was notified by the employer regarding potential employee exposure. (3) The employer shall make assessment for latent tuberculosis infection (LTBI) available to all employees with occupational exposure.
(A) The employer shall ensure that all records, other than the employee medical records more specifically dealt with in subsection (j)(4)(C), required to be maintained by this section shall be made available upon request to the Chief and NIOSH and the local health officer for examination and copying. (D) If, after passing a fit test, the employee subsequently notifies the employer, program administrator, supervisor, or PLHCP that the fit of the respirator is unacceptable, the employee shall be given a reasonable opportunity to select a different respirator facepiece and to be retested.
A copy of the information regarding an exposure incident that was provided to the PLHCP as required by subsection (h)(7)(B). The use of procedures, engineering controls, and other devices or materials to minimize the spread of airborne particles and droplets from an individual who has or exhibits signs or symptoms of having an ATD, such as persistent coughing.
An exposure to a source of ATPs or ATPs-L in which the circumstances of the exposure make the transmission of a disease sufficiently likely that the employee requires further evaluation by a PLHCP. The Director of the National Institute for Occupational Safety and Health, CDC, or his or her designated representative. (5) AirID cases or suspected cases shall be identified, and except in field operations and in settings where home health care or home-based hospice care is being provided, these individuals shall be: (A) Provided with disposable tissues and hand hygiene materials and masked or placed in such a manner that contact with employees who are not wearing respiratory protection is eliminated or minimized until transfer or placement in an AII room or area can be accomplished and; (B) Placed in an AII room or area or transferred to a facility with AII rooms or areas. Instead, you must click
The identity of any local health officer and/or PLHCP consulted; 7. CMS DISCLAIMER: The scope of this license is determined by the ADA, the
including
3. General Industry Safety Orders.
2nd printing, including chapters from the 9th edition on Anthrax and Smallpox, Washington DC: Public Health Foundation, 2008, which is hereby incorporated by reference. 
